• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Ventricular Flutter (2131)
Event Date 11/26/2018
Event Type  Injury  
Manufacturer Narrative
Case-(b)(4).The device was not returned for evaluation and a device history review was unable to be completed as the relevant lot number for the epi-sense device was not reported or able to be subsequently ascertained.The complaint could not be confirmed.
 
Event Description
It was reported that on (b)(6) 2018 a male patient underwent a convergent procedure with epicardial ablation.The patient was in af with an ejection fraction of 30% at the start of the procedure.One hour into the procedure and after 16 successful ablations the patient converted to sinus rhythm with a bradycardic rate of 30 bpm.The patient's blood pressure was depressed, and patient was managed medically by the anesthesiologist.An echo was performed that showed minimal contraction of the whole heart.Patient went into ventricular tachycardia and ventricular fibrillation (vt/vf) multiple times, but the vt/vf event was self-terminated.A balloon pump was placed and then replaced with an impella heart device while the patient was intubated.On (b)(6) 2018 the impella device was removed.An echocardiogram on (b)(6) 2018 showed no pericardial effusion and an ejection fraction of 30%.(question for me only: ef unchanged from the start of the procedure?) on (b)(6) 2018 patient was extubated, is out of icu and recovering.There was no report of any atricure device malfunction.This was a procedural complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer (Section G)
ATRICURE, INC.
7555 innovation way
mason OH 45040
Manufacturer Contact
john ehlert
7555 innovation way
mason, OH 45040
5137554563
MDR Report Key8170246
MDR Text Key130525775
Report Number3011706110-2018-00222
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/26/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-